Skip to main content

Table 1 Performance of HVR1 variants in detecting anti-HCV antibodies

From: Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination

Coating Ag

No positive/no tested

 

Genotype 3

Genotype 1

Genotype 4

Genotype 6

Total

Variant 1

68/85 (80%)

18/25 (72%)

4/4

1/1

91/115 (79.1%)

Variant 2

61/85 (71.7%)

15/25 (60%)

1/4

0/1

77/115 (67%)

Variant 3

74/85 (87%)

24/25 (96%)

2/4

1/1

101/115 (87.8%)

Variant 4

79/85 (92.9%)

22/25 (88%)

4/4

1/1

106/115 (92.2%)

Pool

63/85 (74.1%)

17/25 68%)

2/4

1/1

83/115 (72.2%)

Tetramer

38/85 (44.7%)

10/25 (40%)

0/4

1/1

49/115 (42.6%)